Bitcoin halving
What does that mean?
$2.81T
Total marketcap
$127.32B
Total volume
BTC 50.00%     ETH 15.34%
Dominance

Johnson & Johnson JNJ.MX Stock

2606.85 MXN {{ price }} -0.501144% {{change_pct}}%
COUNTRY
Mexico
Exchange
Mexico
Market Cap
6.34T MXN
LOW - HIGH [24H]
2593.5 - 2619.97 MXN
VOLUME [24H]
266 MXN
{{ volume }}
P/E Ratio
30.11
Earnings per share
86.55 MXN

Johnson & Johnson Price Chart

Johnson & Johnson JNJ.MX Financial and Trading Overview

Johnson & Johnson stock price 2606.85 MXN
Previous Close 2679.99 MXN
Open 2649.25 MXN
Bid 2655 MXN x 400000
Ask 2800 MXN x 400000
Day's Range 2649.25 - 2655 MXN
52 Week Range 2562 - 3490 MXN
Volume 4.91K MXN
Avg. Volume 471 MXN
Market Cap 6.42T MXN
Beta (5Y Monthly) 0.573
PE Ratio (TTM) 28.900633
EPS (TTM) 86.55 MXN
Forward Dividend & Yield 83.22 (3.14%)
Ex-Dividend Date November 21, 2023
1y Target Est N/A

JNJ.MX Valuation Measures

Enterprise Value 6.39T MXN
Trailing P/E 28.900633
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 65.11121
Price/Book (mrq) 89.64177
Enterprise Value/Revenue 64.801
Enterprise Value/EBITDA 182.583

Trading Information

Johnson & Johnson Stock Price History

Beta (5Y Monthly) 0.573
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 3490 MXN
52 Week Low 2562 MXN
50-Day Moving Average 2704.47 MXN
200-Day Moving Average 2801.89 MXN

JNJ.MX Share Statistics

Avg. Volume (3 month) 471 MXN
Avg. Daily Volume (10-Days) 675 MXN
Shares Outstanding 2.41B
Float 2.4B
Short Ratio N/A
% Held by Insiders 0.093%
% Held by Institutions 71.12%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 4.64
Trailing Annual Dividend Yield 0.17%
5 Year Average Dividend Yield 268.00%
Payout Ratio 0.8705
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends January 1, 2023
Most Recent Quarter (mrq) October 1, 2023
Next Fiscal Year End January 1, 2024

Profitability

Profit Margin 35.09%
Operating Margin (ttm) 30.07%
Gross Margin 67.55%
EBITDA Margin 35.49%

Management Effectiveness

Return on Assets (ttm) 10.11%
Return on Equity (ttm) 19.18%

Income Statement

Revenue (ttm) 98.66B MXN
Revenue Per Share (ttm) 38.16 MXN
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 63.95B MXN
EBITDA 35.01B MXN
Net Income Avi to Common (ttm) 13.99B MXN
Diluted EPS (ttm) 91.78
Quarterly Earnings Growth (yoy) 483.80%

Balance Sheet

Total Cash (mrq) 23.51B MXN
Total Cash Per Share (mrq) 9.77 MXN
Total Debt (mrq) 29.92B MXN
Total Debt/Equity (mrq) 42.01 MXN
Current Ratio (mrq) 1.21
Book Value Per Share (mrq) 29.59

Cash Flow Statement

Operating Cash Flow (ttm) 20.28B MXN
Levered Free Cash Flow (ttm) 21.17B MXN

Profile of Johnson & Johnson

Country Mexico
State NJ
City New Brunswick
Address One Johnson & Johnson Plaza
ZIP 08933
Phone 732 524 0400
Website https://www.jnj.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 152700

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Q&A For Johnson & Johnson Stock

What is a current JNJ.MX stock price?

Johnson & Johnson JNJ.MX stock price today per share is 2606.85 MXN.

How to purchase Johnson & Johnson stock?

You can buy JNJ.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Johnson & Johnson?

The stock symbol or ticker of Johnson & Johnson is JNJ.MX.

Which industry does the Johnson & Johnson company belong to?

The Johnson & Johnson industry is Drug Manufacturers-General.

How many shares does Johnson & Johnson have in circulation?

The max supply of Johnson & Johnson shares is 2.43B.

What is Johnson & Johnson Price to Earnings Ratio (PE Ratio)?

Johnson & Johnson PE Ratio is 30.11958500 now.

What was Johnson & Johnson earnings per share over the trailing 12 months (TTM)?

Johnson & Johnson EPS is 86.55 MXN over the trailing 12 months.

Which sector does the Johnson & Johnson company belong to?

The Johnson & Johnson sector is Healthcare.